GlassScriptPhysician profile
Daniel Alexander Heck
NPI 1023691912
$2,607.42
in general payments reported to CMS, 2019-2025
13 companies · $1,588 in 2025
The $1,588 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.00 · 2023: $45.67 · 2024: $950 · 2025: $1,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,584.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $872.36 | 2024-2025 | Impella |
| Shockwave Medical, INC | $462.16 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $233.79 | 2024-2025 | Lifevest |
| Angiodynamics, INC. | $168.24 | 2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $166.54 | 2025 | Corevalve Evolut R |
| Bayer Healthcare Pharmaceuticals INC. | $152.15 | 2023-2025 | |
| Inspire Medical Systems, INC. | $149.99 | 2025 | Inspire |
| Edwards Lifesciences Corporation | $136.69 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kestra Medical Technology Services, INC. | $100.49 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $89.49 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $30.32 | 2023 | Farxiga |
| Harmony Biosciences LLC | $23.00 | 2022 | |
| Alnylam Pharmaceuticals INC. | $22.20 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Heck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.